Company Filing History:
Years Active: 2015-2016
Title: John Poland: Innovator in Polypeptide Technology
Introduction
John Poland is a notable inventor based in San Diego, CA. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides with various applications. With a total of 2 patents, his work has implications in pharmaceutical, agricultural, and industrial contexts.
Latest Patents
John Poland's latest patents include innovations related to Variant CBH I polypeptides. These polypeptides exhibit lignocellulolytic activity, which is crucial for the bioconversion of biomass into fermentable sugars. His inventions also focus on thermostable and thermotolerant forms of these polypeptides, which can be utilized in producing biofuels such as ethanol and methanol. Another significant patent involves variant CBH I polypeptides that have reduced product inhibition, enhancing their effectiveness in various applications.
Career Highlights
Throughout his career, John has worked with prominent companies such as Bp Corporation North America Inc. and Syngenta Participations AG. His experience in these organizations has allowed him to refine his expertise in biotechnology and polypeptide research.
Collaborations
John has collaborated with talented individuals in his field, including Justin Stege and Alexander Varvak. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
John Poland is a distinguished inventor whose work in polypeptide technology has the potential to revolutionize various industries. His innovative patents and collaborations highlight his commitment to advancing biotechnology.